{
    "organizations": [],
    "uuid": "2ad06e9dd8ff456e751a349b27a157acc961ac85",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/idUSL8N1RU2AT",
    "ord_in_thread": 0,
    "title": "BRIEF-OncoArendi Therapeutics To Debut On WSE On April 19",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 17 (Reuters) - ONCOARENDI THERAPEUTICS SA:\n* SAID ON MONDAY THAT WARSAW STOCK EXCHANGE (WSE) DECIDED TO INTRODUCE THE COMPANY’S SHARES AND RIGHTS TO SHARES TO TRADE ON APRIL 19\n* WSE ADMITTED THE COMPANY’S SERIES A, B, C, D AND F SHARES TO TRADE AND 2.0 MLN RIGHTS TO COMPANY’S SERIES F SHARES ON APRIL 12\n* ONCOARENDI THERAPEUTICS SAID ON MARCH 28 THAT ISSUE PRICE FOR ITS SHARES IN IPO HAS BEEN SET AT 29 ZLOTYS PER SHARE\n* COMPANY SPECIALIZES IN DEVELOPMENT AND COMMERCIALIZATION OF NEW DRUGS USED IN TREATMENT OF CANCERS AND RESPIRATORY DISEASES\n* IN DEC, CO INFORMED THAT FROM IPO PROCEEDS IT PLANS TO FINANCE ITS CURRENTLY UNDERTAKEN R&D PROJECTS AND TO FUND NEW PROJECTS\nSource text: nEM6rKG3qa\nFurther company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-17T18:49:00.000+03:00",
    "crawled": "2018-04-18T18:30:34.007+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "oncoarendi",
        "therapeutic",
        "sa",
        "said",
        "monday",
        "warsaw",
        "stock",
        "exchange",
        "wse",
        "decided",
        "introduce",
        "company",
        "share",
        "right",
        "share",
        "trade",
        "april",
        "wse",
        "admitted",
        "company",
        "series",
        "b",
        "c",
        "f",
        "share",
        "trade",
        "mln",
        "right",
        "company",
        "series",
        "f",
        "share",
        "april",
        "oncoarendi",
        "therapeutic",
        "said",
        "march",
        "issue",
        "price",
        "share",
        "ipo",
        "set",
        "zloty",
        "per",
        "share",
        "company",
        "specializes",
        "development",
        "commercialization",
        "new",
        "drug",
        "used",
        "treatment",
        "cancer",
        "respiratory",
        "disease",
        "dec",
        "co",
        "informed",
        "ipo",
        "proceeds",
        "plan",
        "finance",
        "currently",
        "undertaken",
        "r",
        "project",
        "fund",
        "new",
        "project",
        "source",
        "text",
        "nem6rkg3qa",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}